Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing the quality of electronic health record data and the claims linked data for target trial emulation studies.

JAMIA open·2026
Same author

Digital Registrar: A Schema-First Framework for Multi-Cancer Privacy-Preserving Pathology Abstraction via Local LLMs.

Diagnostics (Basel, Switzerland)·2026
Same author

Effectiveness of THC-containing cannabis for inflammatory bowel disease: a systematic review.

Journal of cannabis research·2026
Same author

Sequential Safety Surveillance of RSVpreF Vaccination During Pregnancy Early in the Postapproval Period.

JAMA network open·2026
Same author

Joint Position Statement from the Society for Birth Defects Research and Prevention, the Organization of Teratology Information Specialists, and the Developmental Neurotoxicology Society: A Call for Implementation of Risk Evaluation and Mitigation Strategies to Reduce Prenatal Exposure to Valproate.

Birth defects research·2026
Same author

Risk of Fetal Exposure to Teratogenic Medications: Development of Evidence for the Teratogenic Risk Impact and Mitigation (TRIM) Tool.

Drug safety·2026
Same journal

RE: advancing observational research on arts and health: theory-informed approaches using the RADIANCE framework.

American journal of epidemiology·2026
Same journal

Maternal Cesarean Section and Offspring ASD or ADHD Risk: A Nurses' Health Study II Analysis.

American journal of epidemiology·2026
Same journal

Immigration and epigenetic age acceleration in the health and retirement study: differences Between Hispanics and Non-Hispanics.

American journal of epidemiology·2026
Same journal

Age-period-cohort analysis of low birth weight, early term delivery, induction and csection, US births 1990-2019.

American journal of epidemiology·2026
Same journal

A measurement comparability study to support instrument harmonization in the Canadian longitudinal study on aging.

American journal of epidemiology·2026
Same journal

Attending an Historically Black College or University and all-cause mortality in US Black adults.

American journal of epidemiology·2026
See all related articles
  1. Home
  3. Peprvision: A Visualization Framework For Pharmacoepidemiology Research.
  1. Home
  3. Peprvision: A Visualization Framework For Pharmacoepidemiology Research.

Related Experiment Video

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging
11:07

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging

Published on: November 24, 2021

PEPRVision: a visualization framework for Pharmacoepidemiology research.

Yanning Wang1,2, Hung-Kai Chen1, Wen Wen1

  • 1Department of Pharmaceutical Outcomes and Policy, University of Florida, Gainesville, FL 32611, United States.

American Journal of Epidemiology
|June 11, 2026

View abstract on PubMed

Summary
This summary is machine-generated.

PEPRVision transforms complex healthcare data into easy-to-understand graphics for pharmacoepidemiology research. This tool aids in evaluating patient profiles, improving study design, and enhancing the clinical relevance of research findings.

Keywords:
algorithm validationchart reviewobservational studiespatient episode profile retrieval (PEPR)pharmacoepidemiologyphenotyping

More Related Videos

Improved Visualization and Quantitative Analysis of Drug Effects Using Micropatterned Cells
15:41

Improved Visualization and Quantitative Analysis of Drug Effects Using Micropatterned Cells

Published on: December 2, 2010

Facilitating the Analysis of Immunological Data with Visual Analytic Techniques
10:58

Facilitating the Analysis of Immunological Data with Visual Analytic Techniques

Published on: January 2, 2011

Related Experiment Videos

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging
11:07

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging

Published on: November 24, 2021

Improved Visualization and Quantitative Analysis of Drug Effects Using Micropatterned Cells
15:41

Improved Visualization and Quantitative Analysis of Drug Effects Using Micropatterned Cells

Published on: December 2, 2010

Facilitating the Analysis of Immunological Data with Visual Analytic Techniques
10:58

Facilitating the Analysis of Immunological Data with Visual Analytic Techniques

Published on: January 2, 2011

Area of Science:

  • Pharmacoepidemiology
  • Health Informatics
  • Data Visualization

Background:

  • Medical chart review is standard in epidemiology but structured healthcare data, like administrative claims, are difficult to interpret.
  • Existing data formats hinder efficient patient profile review in pharmacoepidemiologic research.

Purpose of the Study:

  • Introduce PEPRVision, a novel visualization framework to translate structured longitudinal healthcare data into intuitive graphics.
  • Enhance patient profile review and pattern recognition in pharmacoepidemiology.

Main Methods:

  • Developed PEPRVision based on preattentive visual processing principles.
  • Utilized visual attributes (color, position, shape, length) for rapid pattern recognition.
  • Demonstrated the framework using US administrative claims data across four case studies.

Main Results:

  • PEPRVision effectively supports evaluation of algorithms for health outcomes (e.g., congenital hearing loss).
  • The framework aids in identifying biases like reverse causation in drug safety studies.
  • Facilitates assessment of potential teratogenicity signals and identifies exposure mechanisms for risk mitigation.

Conclusions:

  • PEPRVision enhances the validity and clinical relevance of pharmacoepidemiologic research by enabling review of patient-level variation.
  • Complements population-based causal inference studies by providing intuitive data interpretation.
  • Offers a valuable tool for improving study design and risk management strategies in drug safety research.